Clinical studies suggest that the mRNA vaccine could aid in treating pancreatic cancer, one of the most lethal forms of ...
The University of Hawaii Cancer Center is located in Kakaako. UH and The Queen's Health Systems will work to develop the ...
AMLX has had major setbacks in its lifecycle, including the voluntary withdrawal of an approved drug. Click here to find out ...
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.
Glucagon-like peptite-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With ...
Belgium plans to reinforce its global competitiveness in clinical research as the new government sets an ambitious course for pharma progress.
Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies ...
Reducing glucocorticoid use in the treatment of giant cell arteritis and polymyalgia rheumatica — due to the steroid’s host ...
Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase” or "Company”), today announced the appointment of two pharma ...
Data confirms Versamune ® HPV has potential as a broadly effective treatment of HPV16-associated cancers - Initiation of Phase 3 trial in HPV16-positive HNSCC planned for Q1 2025 ...
Phase 1b Study receives lead clinical site approval KELOWNA, BC / ACCESS Newswire / February 24, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria") ...
Sterotherapeutics, a leading biopharmaceutical company dedicated to advancing innovative therapies, is announcing the launch of a Phase 2 clinical trial for ST-002, a novel drug candidate for patients ...